Výsledky vyhledávání - "Armando Carpino"

Early Diastolic Dysfunction after Cancer Chemotherapy: Primary Endpoint Results of a Multicenter Cardio-Oncology Study

Autor: Vito, Calabrese, Pierantonio, Menna, Ombretta, Annibali, Grazia, Armento, Armando, Carpino, Elisabetta, Cerchiara, Carlo, Greco, Francesco, Marchesi, Paolo, Spallarossa, Giuseppe, Toglia, Giorgio, Reggiardo, Giorgio, Minotti, Giuseppe, Tonini

Publikováno v: Chemotherapy. 63:55-63

Asymptomatic diastolic dysfunction (DD) with preserved left ventricular ejection fraction (LVEF) is suspected to precede late cardiac events in cancer survivors treated by chemotherapy. We conducted the first multicenter study of early DD induced by

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1795668919838ae25e66d44d2328ea2
https://doi.org/10.1159/000486761

Zobrazit plný text záznamu

Trastuzumab plus weekly epirubicin and paclitaxel for locally advanced and metastatic breast cancer: preliminary results of a feasibility-phase II study aimed at cardiotoxicity

Autor: Isabella Sperduti, Emilio Bria, Fiorentino Izzo, Francesco Tropea, Cecilia Nisticò, Armando Carpino, Francesco Cognetti, Monica Fornier, Edmondo Terzoli, Vanja Vaccaro, Federica Cuppone

Publikováno v: Anti-Cancer Drugs. 20:109-114

A feasibility-phase II study was conducted to assess the cardiotoxicity of weekly trastuzumab, epirubicin, and paclitaxel in patients with human epidermal growth factor receptor-2-positive metastatic breast cancer. Untreated patients with human epide

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e15a7e9598239499d5e4b357ba5b1f65
https://doi.org/10.1097/cad.0b013e32831bc09b

Zobrazit plný text záznamu

Pegylated liposomal doxorubicin in combination with gemcitabine: a phase II study in anthracycline-naïve and anthracycline pretreated metastatic breast cancer patients

Autor: A. M. Cianciulli, Francesco Cognetti, Mariangela Ciccarese, Alessandra Felici, Armando Carpino, Nello Salesi, Paolo Carlini, Paola Papaldo, Marcella Mottolese, Diana Giannarelli, Alessandra Fabi, Isabella Sperduti, Vito Lorusso, Gianluigi Ferretti

Publikováno v: Cancer Chemotherapy and Pharmacology. 57:615-623

Background: The aim of the study was to assess the toxicity profile, activity in terms of response rate, time to progression, overall survival, and quality of life of pegylated liposomal doxorubicin (PLD) and gemcitabine combination in chemo-naive an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c4e209cab94995d873ea16cc96b8557
https://doi.org/10.1007/s00280-005-0116-2

Zobrazit plný text záznamu

Effects of Oral Propafenone Therapy on Chronic Myocardial Pacing Threshold

Autor: Armando Carpino, Roberto Boccadamo, Salvatore Toscano, Roberto Serdoz, Giuliano Altamura, Leopoldo Bianconi, Anna Patrizia Iesi

Publikováno v: Pacing and Clinical Electrophysiology. 15:148-154

The effects of oral propafenone therapy on pacing threshold were studied in 36 patients chronically paced for sick sinus syndrome or AV block. The pacemakers, all unipolar models and with noninvasive threshold measurement facilities, were: 9 VVI, 15

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5c9dc15042222a36ca59545604b0823
https://doi.org/10.1111/j.1540-8159.1992.tb03058.x

Zobrazit plný text záznamu

Weekly epirubicin and paclitaxel with granulocyte colony-stimulating factor support in previously untreated metastatic breast cancer patients: a phase II study

Autor: Francesco Cognetti, Emilio Bria, Monica Fornier, Armando Carpino, Cecilia Nisticò, Edmondo Terzoli, Andrea Pace, Isabella Sperduti, Federica Cuppone

We conducted a phase II study to determine the activity and tolerability of weekly epirubicin-paclitaxel and granulocyte colony-stimulating factor in breast cancer patients untreated for metastatic disease. The phase II study was designed following t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d899631373bfeaa4050212799d949bb9
http://hdl.handle.net/11562/873828

Zobrazit plný text záznamu

Troponin-T and myoglobin plus echocardiographic evaluation for monitoring early cardiotoxicity of weekly epirubicin-paclitaxel in metastatic breast cancer patients

Autor: Gianluigi Ferretti, Gaetano Vitelli, Giuseppe Toglia, Silverio Tomao, Armando Carpino, Federica Cuppone, Francesco Cognetti, Isabella Sperduti, Emilio Bria, Edmondo Terzoli, Cecilia Nisticò, Francesca Calabretta

Increased serum level of troponin-T and myoglobin has been recently reported to be related to cumulative anthracycline exposure. Left ventricular ejection fraction seems accurate in monitoring systolic function according to the latest version of Toxi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c8b9c23e079a6b3accd131b75265a02
http://hdl.handle.net/11573/133514

Zobrazit plný text záznamu

Toxicity and activity of docetaxel in anthracycline-pretreated breast cancer patients: a phase II study

Autor: Armando Carpino, A.M. D'Ottavio, Virginia Ferraresi, A. Vaccaro, Annelisa Marsella, Francesco Cognetti, Cecilia Nisticò, Paola Papaldo, Michele Milella, Maria Francesca Thorel, Edmondo Terzoli, Diana Giannarelli

Publikováno v: American journal of clinical oncology. 23(2)

Docetaxel has proven effective in advanced breast cancer. Myelosuppression and cumulative fluid retention syndrome are troublesome, potentially avoidable toxicities. In this consecutive cohort study, docetaxel (100 mg/m2 by 1 hour i.v. infusion, q3 w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6ab105493009c72874c49ebbdc9fc3b
https://pubmed.ncbi.nlm.nih.gov/10776972

Zobrazit plný text záznamu

Phase II Trial of Primary Systemic Therapy (PST) with Docetaxel (D) Followed by High-Dose Epirubicin in Combination with Cyclophosphamide (EC) Plus Concurrent Trastuzumab (T) For Stage II-III HER-2 Positive Breast Cancer Patients (PTS)

Autor: Edoardo Pescarmona, Letizia Perracchio, A Di Benedetto, L. Di Lauro, M. Mottolese, Armando Carpino, L. Pizzuti, Domenico Sergi, Claudio Botti, Patrizia Vici

Publikováno v: Annals of Oncology. 23:ix142

Background PST with taxanes, anthracycline-containing regimens and T showed a high percentage of pathologic complete response (pCR); T administered concurrently with chemotherapy is more effective, but the combination with anthracyclines may be at ri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2841efd9a7b456471bbffba264712134
https://doi.org/10.1016/s0923-7534(20)32973-2

Zobrazit plný text záznamu

A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study

Autor: Laura Pizzuti, Patrizia Vici, Armando Carpino, Francesco Giotta, Diana Giannarelli, A. Latorre, Luigi Di Lauro, Massimo Lopez, Claudio Botti, Domenico Sergi, Giuseppe Colucci, Gianfranco Filippelli, Pasquale Perri, Enrico Vizza

Publikováno v: Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research, Vol 30, Iss 1, p 39 (2011)

Background To evaluate activity and tolerability of two anthracycline-containing regimens as first-line treatment for anthracycline-naïve relapsed breast cancer patients. Methods Patients with relapsed breast cancer not previously treated with adjuv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4adad4fbb64935a8f460db93eaa87bef
http://europepmc.org/articles/PMC3082232

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání